When a pharmacist needs to check if two Egyptian drugs interact—there is no system to consult.
When a physician must decide if a locally-manufactured medication is safe during pregnancy—there is no Egyptian resource.
When a hospital wants clinical decision support for their electronic prescribing—there is no database to integrate.
At our core, we are creating four comprehensive databases from the ground up—purpose-built digital infrastructure that Egypt's healthcare system has never had.
The definitive registry of Egyptian pharmaceutical products. Every drug, every formulation, every manufacturer—structured, standardized, and connected to global medical knowledge.
Every medication mapped to international disease classifications (ICD-10 and ICD-11), making the Egyptian market searchable by indication and route for the first time.
Questions that today require phone calls and catalog hunting. Answered in seconds.A complete safety classification system for medication use during pregnancy and breastfeeding.
Clear risk levels. Clinical guidance. Built specifically for the drugs available in the Egyptian market.
Comprehensive adverse effect profiles with the depth that clinical practice demands: frequency data, severity classifications, route-specific risks, and critical alerts for special populations.
The elderly, patients with kidney disease, liver impairment, diabetes, and other chronic conditions—all covered.
A complete interaction screening system covering Egyptian drug combinations.
Severity ratings. Mechanism insights. Clinical management guidance. Designed for the prescribing patterns Egyptian healthcare professionals actually encounter.
Databases are the foundation. But we're building something more.
A patient with diabetes, hypertension, and chronic kidney disease doesn't need generic drug information. They need to know: For my specific conditions, what are the real risks of this prescription?
A physician managing a complex patient doesn't want to cross-reference five sources. They need one system that understands the full picture.
Not generic information. Personalized clinical intelligence.
The front line of medication safety. Checking interactions, verifying pregnancy safety, counseling patients—using a system that knows their market.
Making prescribing decisions under time pressure. Accessing safety information instantly. Getting personalized alerts for complex patients without manual cross-referencing.
Managing chronic conditions. Finally understanding what their medications mean for their specific health situation.
Investing in digital transformation. Finally having databases that integrate with Egyptian formularies and power real clinical decision support.
Scaling to cover all Egyptians by 2032. Having the medication safety infrastructure that modern universal healthcare requires.
This infrastructure is being built without a pharmaceutical intelligence layer.
We are building what's missing.
We are not building an app. We are building infrastructure.
Four foundational databases. A personalized safety platform. The backbone for pharmaceutical intelligence in Egypt—and potentially the entire Arabic-speaking region.
When Saudi Arabia built its national health information exchange, it cost hundreds of millions of dollars and required a decade-long partnership with international vendors. The UAE's Malaffi system. Qatar's national health platforms. These are billion-dollar government initiatives.
Egypt—with 110 million people, the largest pharmaceutical market in Africa, and healthcare digitization accelerating under the Universal Health Insurance program—has no equivalent pharmaceutical intelligence infrastructure.
We are building it.
Not with government budgets. Not with multinational vendors. But with the same ambition and scope—because Egyptian patients and healthcare professionals deserve the same tools.